News

Iran Conflict Drives Glove Price Increases, Raising Supply Concerns for Clinical Laboratories

Rising glove prices tied to Middle East supply chain disruptions could increase costs for clinical laboratories and healthcare providers, even as pandemic-era stockpiles help cushion immediate shortages

Written byJanette Wider
| 2 min read
Global supply chain disruptions are pushing glove manufacturers to raise prices, creating new operational challenges for laboratories and hospitals.
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Clinical laboratories may soon feel the effects of a growing global supply chain challenge as escalating conflict in the Middle East drives up the cost of medical gloves and other healthcare consumables.

According to a Reuters report, manufacturers of synthetic rubber gloves have already increased prices by roughly 40% following disruptions tied to the Iran war. Analysts warn that continued supply chain instability could lead to shortages later this spring if conditions worsen.

The issue centers on soaring prices for naphtha, a petroleum-derived raw material used to manufacture nitrile latex, a key component in many medical gloves. The closure of the Strait of Hormuz has disrupted global energy markets, sending raw material costs sharply higher and forcing manufacturers to pass those increases on to healthcare customers.

For laboratory professionals, glove availability remains a critical operational concern. Gloves are among the most frequently used consumables in clinical laboratories, supporting specimen collection, processing, testing, and safety protocols. Significant price increases can place additional strain on laboratory budgets already facing inflationary pressure from staffing, reagents, and equipment costs.

Major glove manufacturers, including Top Glove and Hartalega Holdings, indicated that additional price increases may be necessary as raw material costs continue to climb. Some manufacturers have also warned that prolonged disruptions could eventually impact global glove production.

Hartalega Holdings CEO Kuan Mun ⁠Leong told Reuters that increased input costs mean "glove prices have been adjusted accordingly", and that longer term, "we are concerned that if this war continues, there could be an impact on global glove supply".

Pandemic lessons provide a buffer

Unlike the shortages experienced during the COVID-19 pandemic, many hospitals, laboratories, and manufacturers now maintain larger inventory reserves. Those stockpiles may help soften the immediate impact of supply disruptions and provide organizations additional time to adjust procurement strategies.

Still, the situation serves as another reminder of how geopolitical events can quickly affect laboratory operations. While current supplies remain stable, laboratory leaders may want to monitor inventory levels, supplier communications, and purchasing costs closely as uncertainty surrounding global supply chains continues.

This article was created with the assistance of Generative AI and has undergone editorial review before publishing.

Add Today's Clinical Lab as a preferred source on Google

Add Today's Clinical Lab as a preferred Google source to see more of our trusted coverage.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...